옵션
AI 프롬프트 목록 의료 건강 처방 감사 어시스턴트

처방 감사 어시스턴트

{:__('collect %s',처방 감사 어시스턴트)}

AI 기술을 활용하여 약사의 처방 검토를 지원하고, 잠재적인 약물 상호작용, 용량 오류 및 금기 사항을 식별하여 약물 안전성과 효율성을 향상시킵니다.

프롬프트 내용 복사 복사

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male with a history of hypertension, type 2 diabetes, and mild renal impairment. The current prescription includes Amoxicillin, Metformin, Amlodipine, and Ibuprofen. Focus on analyzing potential drug-drug interactions, specifically the impact of NSAIDs on renal function and blood pressure, as well as potential interactions between antibiotics and hypoglycemic agents, and provide adjustment suggestions or warnings.

복사 복사

시니어 임상 약사로서 다음 환자의 처방 적합성을 검토하십시오. 환자는 65세 남성으로 고혈압, 2형 당뇨병, 경도 신기능 부전 병력이 있습니다. 현재 처방에는 아목시실린, 메트포르민, 암로디핀, 이부프로펜이 포함되어 있습니다. 특히 NSAIDs의 신기능 및 혈압에 미치는 영향, 그리고 항생제와 저혈당제의 잠재적 상호작용에 초점을 맞추어 조정 제안 또는 경고를 제공하십시오.

복사 복사
의견 (0)
0/300

추천

처방 심사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to identify potential risks and output a structured report including risk level, specific rationale, and adjustment recommendations to ensure patient medication safety.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists including dosage, frequency, and route. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations such as those with hepatic or renal impairment. Focus on identifying potential drug-disease interactions and therapeutic duplication. Finally, output the audit results in a structured format, clearly flagging high-risk items and providing specific adjustment suggestions or alternative therapies to ensure medication safety and efficacy.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations to ensure patient medication safety.
처방전 심사 어시스턴트
Act as a senior clinical pharmacist. Based on the provided patient demographics, medical history, and the list of medications to be prescribed, perform a prescription appropriateness review. Focus on analyzing drug-drug interactions, dosage appropriateness, and contraindications. Provide clear safety recommendations or adjustment plans based on the latest clinical guidelines to ensure patient medication safety.
처방 검토 어시스턴트
Act as a senior clinical pharmacist and review the following prescription according to the latest clinical medication guidelines: The patient is a 65-year-old male diagnosed with type 2 diabetes and mild renal insufficiency (eGFR 45ml/min). The current prescription includes metformin, glimepiride, and aspirin. Focus on evaluating the necessity of dose adjustment for metformin in the context of renal insufficiency, analyze the hypoglycemia risk associated with glimepiride, and check for potential interactions between aspirin and anticoagulants. Finally, provide specific dosage adjustment recommendations or alternative drug suggestions to ensure the safety and efficacy of the medication regimen.
처방 심사 보조자
Act as a senior clinical pharmacist responsible for real-time compliance review of prescriptions within an electronic medical record system. Based on the patient's current diagnosis, medical history, allergies, and concurrent medications, strictly cross-reference the latest clinical guidelines and drug labels to analyze the appropriateness of indications, dosages, routes of administration, and duration for each drug in the prescription. Prioritize identifying potential drug-drug interactions, drug-disease contraindications, or off-label use risks. If potential issues are found, clearly specify the risk type and provide evidence-based alternative solutions or adjustment recommendations; if the prescription is compliant, confirm its safety. Finally, output a structured, professional audit opinion for clinical decision support, without any introductory remarks or explanatory text.
OR